Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.06
+0.09 (1.36%)
At close: May 9, 2025, 4:00 PM
7.38
+0.33 (4.61%)
After-hours: May 9, 2025, 7:49 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $61.51 million as of May 9, 2025. Its market cap has decreased by -44.19% in one year.
Market Cap
61.51M
Enterprise Value
92.20M
1-Year Change
-44.19%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $61.51M, a decrease of -96.74%. That is a compound annual growth rate of -29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 61.60M | -56.59% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |